Traduction de «population-based breast cancer » (Néerlandais → Français) :

40. Theberge I, Hebert-Croteau N, Langlois A, Major D, Brisson J. Volume of screening mammography and performance in the Quebec population-based Breast Cancer Screening Program.
39. Theberge I, Hebert-Croteau N, Langlois A, Major D, Brisson J. Volume of screening mammography and performance in the Quebec population-based Breast Cancer Screening Program.

(Jernström 2005) Jernström H, Loman N, Johansson OT et al. Impact of teenage oral contraceptive use in a population-based series of earlyonset breast cancer cases who have undergone BRCA mutation testing. Eur J Cancer 2005; 41:2312-20.
(Jernström 2005) Jernström H, Loman N, Johansson OT et al. Impact of teenage oral contraceptive use in a population-based

US and European regulatory submissions are planned in the 2009 fourth quarter for the use of Zometa in adjuvant breast cancer in premenopausal women based on published anti-cancer data for this indication.
Des demandes d’autorisation aux Etats-Unis et en Europe sont prévues au quatrième trimestre 2009 pour l’utilisation de Zometa en tant qu’adjuvant dans le traitement du cancer du sein chez les femmes préménopausées sur la base des données anticancer publiées pour cette indication.

Table 7: Evidence form systematic reviews and meta analysis (breast cancer mortality reduction in intervention group) Study ID Ref Population Intervention Results of meta-analysis Comments Level of evidence
Table 9: Evidence form systematic reviews and meta analysis (breast cancer mortality reduction in intervention group) Study ID Ref Population Intervention Results of meta-analysis Comments Level of evidence

72. Kerr J. Review of the effectiveness of infrared thermal imaging (thermography) for population screening and diagnostic testing of breast cancer.
71. Kerr J. Review of the effectiveness of infrared thermal imaging (thermography) for population screening and diagnostic testing of breast cancer.

US and European regulatory submissions were completed in late 2009 for the use of Zometa in adjuvant breast cancer in premenopausal women based on published anticancer data for this indication.
Des demandes d’autorisation aux Etats-Unis et en Europe ont été complétées à fin 2009 pour l’utilisation de Zometa en tant qu’adjuvant dans le traitement du cancer du sein chez les femmes préménopausées sur la base des données anticancer publiées pour cette indication.

Application Presentation: A web-based Support System for the belgian Breast Cancer Screening Program(.Powerpoint) by Eddy Husson, Informatique Médicale et Biostatistique, Université de Liège (B)
Application Presentation: Symposium A web-based Support System for the belgian Breast Cancer Screening Program (.Powerpoint) by Eddy Husson, Informatique Médicale et Biostatistique, Université de Liège (B)